Published in Clin Exp Rheumatol on January 23, 2013
The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med (2005) 3.26
Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med (2004) 3.03
Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS. J Rheumatol (2008) 2.05
Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome. J Rheumatol (2012) 1.97
Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med (2005) 1.93
Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum (2004) 1.92
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum (2004) 1.87
Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med (2007) 1.64
Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum (2007) 1.62
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum (2002) 1.59
{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. Blood (2009) 1.47
Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.47
Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Arthritis Rheum (2005) 1.45
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun (2009) 1.39
Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis. J Rheumatol (2011) 1.39
Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum (2003) 1.38
The geoepidemiology of Sjögren's syndrome. Autoimmun Rev (2009) 1.37
Pathogenesis of Sjögren's syndrome: what we know and what we should learn. J Autoimmun (2012) 1.35
Evidence for coxsackievirus infection in primary Sjögren's syndrome. Arthritis Rheum (2004) 1.29
Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis. Arthritis Res Ther (2010) 1.23
Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol (2008) 1.23
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I. Arthritis Rheum (2011) 1.18
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum (2009) 1.17
Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. J Rheumatol (2002) 1.17
Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) (2009) 1.17
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes. Clin Cancer Res (2007) 1.16
The management of Sjögren's syndrome. Nat Clin Pract Rheumatol (2006) 1.12
Sjögren's syndrome. Annu Rev Pathol (2013) 1.10
Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine (Baltimore) (2012) 1.09
Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun (2003) 1.09
Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun (2012) 1.08
Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol (2007) 1.05
Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther (2011) 1.04
Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther (2008) 1.02
Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci (2006) 1.00
The liver in brucellosis. Clin Gastroenterol Hepatol (2007) 1.00
Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. Arthritis Rheum (2006) 0.99
Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol (2002) 0.98
Wound healing: immunological aspects. Injury (2006) 0.98
Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med (2002) 0.98
Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med (2006) 0.98
Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis. Rheum Dis Clin North Am (2008) 0.97
Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci (2002) 0.96
IgG4 syndrome: old disease, new perspective. J Rheumatol (2010) 0.94
Neuroendocrine dysfunction in Sjogren's syndrome. Neuroimmunomodulation (2008) 0.94
The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta (2004) 0.92
Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum (2013) 0.91
Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun (2011) 0.91
Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin North Am (2004) 0.90
Lymphoproliferation in autoimmunity and Sjögren's syndrome. Curr Rheumatol Rep (2003) 0.89
Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome. J Rheumatol (2008) 0.88
Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun (2012) 0.88
Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis (2003) 0.87
Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen. Autoimmunity (2007) 0.87
Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One (2013) 0.87
Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms. Presse Med (2012) 0.87
Sjögren's Syndrome. Semin Respir Crit Care Med (2007) 0.87
Sjogren's syndrome. Autoimmunity (2004) 0.87
Determinants of pulmonary arterial hypertension in scleroderma. Semin Arthritis Rheum (2007) 0.86
Is Sjögren's syndrome a retroviral disease? Arthritis Res Ther (2011) 0.86
Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. J Infect Dis (2011) 0.86
Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res (Hoboken) (2014) 0.86
Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. J Autoimmun (2012) 0.85
Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity. Arthritis Rheum (2011) 0.85
Minor salivary gland inflammatory lesions in Sjögren syndrome: do they evolve? J Rheumatol (2013) 0.84
New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. Curr Opin Rheumatol (2013) 0.84
Recent advances in the management of ocular complications of Sjögren's syndrome. Curr Allergy Asthma Rep (2005) 0.84
Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum (2006) 0.84
Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry (2010) 0.84
Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med (2006) 0.83
Autoimmunity and pathophysiology. J Autoimmun (2007) 0.83
Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients. Neuroimmunomodulation (2007) 0.81
Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol (2009) 0.81
No evidence for increased prevalence of JAK2 V617F in women with a history of recurrent miscarriage. Br J Haematol (2008) 0.80
Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J Med Chem (2004) 0.80
Linear epitopes of two different autoantigens-La/SSB and myelin basic protein--with a high degree of molecular similarity, cause different humoral immune responses. J Autoimmun (2003) 0.80
Chest CT findings in patients with inflammatory myopathy and Jo1 antibodies. Eur J Radiol (2007) 0.80
Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum (2011) 0.80
Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells. Leuk Res (2006) 0.80
Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome. Arthritis Rheum (2002) 0.80
Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics. Medicine (Baltimore) (2007) 0.79
Severe gastrointestinal involvement in systemic sclerosis. Clin Rheumatol (2006) 0.79
Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. J Rheumatol (2009) 0.78
Autoimmunity and coxsackievirus infection in primary Sjogren's syndrome. Ann N Y Acad Sci (2005) 0.78
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study. Arthritis Res Ther (2010) 0.78
Ultrasonography of salivary glands: an evolving approach for the diagnosis of Sjögren's syndrome. Nat Clin Pract Rheumatol (2008) 0.78
IL-2 and IL-10 production by human CD4+T cells is differentially regulated by p38: mode of stimulation-dependent regulation of IL-2. Neuroimmunomodulation (2004) 0.78
Brief report: adrenal autoimmunity in primary Sjögren's syndrome. Arthritis Rheum (2012) 0.78